Abstract:Background: Depression and anxiety are common comorbid diseases of constipation. Fecal microbiota transplantation (FMT) significantly relieves gastrointestinal-related symptoms, but its impact on psychiatric symptoms remains uncharted. Methods: We collected fecal and serum samples before and after FMT from 4 functional constipation patients with psychiatric symptoms and corresponding donor stool samples. We categorized the samples into two groups: before FMT (Fb) and after FMT (Fa). Parameters associated with constipation, depression, and anxiety symptoms were evaluated. Metagenomics and targeted neurotransmitter metabolomics were performed to investigate the gut microbiota and metabolites. 5-hydroxytryptamine (5-HT) biosynthesis was detected in patients' fecal supernatants exposed to the QGP-1 cell model in vitro. Results: Our study demonstrated that patient's constipation, depression, and anxiety were improved after FMT intervention. At the genus level, relative abundance of g_Bacteroides and g_Klebsiella decreased in the Fa group, while g_Lactobacillus, and g_Selenomonas content increased in the same group. These observations suggest a potential involvement of these genera in the pathogenesis of constipation with psychiatric symptoms. Metabolomics analysis showed that FMT intervention decreased serum 5-HT levels. Additionally, we found that species, including s_Klebsiella sp. 1_1_55, s_Odoribacter splanchnicus, and s_Ruminococcus gnavus CAG:126, were positively correlated with 5-HT levels. In contrast, s_Acetobacterium bakii, s_Enterococcus hermanniensis, s_Prevotella falsenii, s_Propionispira arboris, s_Schwartzia succinivorans, s_Selenomonas artemidis, and s_Selenomonas sp. FC4001 were negatively correlated with 5-HT levels. Furthermore, we observed that patients' fecal supernatants increased 5-HT biosynthesis in QGP-1 cells. Conclusion: FMT can relieve patients' constipation, depression, and anxiety symptoms by reshaping gut microbiota. The 5-HT level was associated with an altered abundance of specific bacteria or metabolites. This study provides specific evidence for FMT intervention in constipation patients with psychiatric symptoms.

Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review

Current landscape of fecal microbiota transplantation in treating depression

Pick fecal microbiota transplantation to enhance therapy for major depressive disorder

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report

Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options

Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation

Fecal Microbiota Transplantaion in the treatement of mood disorders : A literature review

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

Microbiota-Orientated Treatments for Major Depression and Schizophrenia

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Research progress on intestinal flora and depression

[Fecal Microbiota Transplants in the Context of (Child and Adolescent) Psychiatric Disorders]

The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches

New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside

Amelioration of depressive symptoms on Fawn-Hooded rats through the 'healthy' fecal microbiota transplantation

The microbiota–gut–brain axis and its modulation in the therapy of depression: Comparison of efficacy of conventional drugs and traditional Chinese medicine approaches

Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression

Human Gut Microbiota for Diagnosis and Treatment of Depression

Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety

Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme?

Probiotics for the treatment of depression and its comorbidities: A systemic review